Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,246,597
-$266,549 QoQ
Shares Held
51,769
-3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,193
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NWAM LLC holds $48,579,826 across 13 Drug Manufacturers - General names. PFE ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,632 | $18,749,491 | |
| 2 | ABBV |
AbbVie Inc.
|
27,356 | $6,883,863 | |
| 3 | JNJ |
Johnson & Johnson
|
25,030 | $6,356,869 | |
| 4 | AMGN |
Amgen Inc
|
16,081 | $5,823,251 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,971 | $2,694,773 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,024 | $1,645,452 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,139 | $1,390,889 | |
| 8 | PFE |
Pfizer Inc
This page
|
51,769 | $1,246,597 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,246,597 | 51,769 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,513,146 | 53,887 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,079,564 | 43,356 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,111,692 | 43,630 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $1,158,429 | 47,790 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $1,213,963 | 47,907 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,337,509 | 50,415 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,572,483 | 54,336 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,536,437 | 54,912 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,476,549 | 53,209 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,805,276 | 62,705 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,140,659 | 64,536 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,670,964 | 72,818 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,852,328 | 69,910 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,770,546 | 73,586 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,318,933 | 75,844 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,046,809 | 77,185 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,704,816 | 71,563 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,969,518 | 67,223 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,859,906 | 66,494 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,567,368 | 65,561 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,491,174 | 68,760 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $3,183,623 | 86,488 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $3,142,177 | 85,618 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,991,202 | 91,474 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,870,530 | 57,308 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||